US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Shire PLC

179.20

0.0000

Volume:- -

Turnover:- -

Market Cap:54.42B

PE:11.38

High:179.20

Open:179.20

Low:179.20

Close:179.20

52wk High:182.47

52wk Low:123.73

Shares:303.66M

Float Shares:196.92M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):15.75

EPS(LYR):14.14

ROE:--

ROA:--

PB:1.46

PE(LYR):12.68

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Shire PLC

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.shire.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Shire plc, a biotechnology company, focuses on serving people with rare diseases and other specialized conditions. The company develops products across core therapeutic areas, including hematology, immunology, neuroscience, ophthalmics, lysosomal storage disorders, gastrointestinal/internal medicine/endocrine, and hereditary angioedema. It also focuses on developing a franchise in oncology and a pipeline in ophthalmics. Shire plc was founded in 1986 and is based in Dublin, Ireland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SHPG/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPG\",,,,,undefined,":{"symbol":"SHPG","market":"US","secType":"STK","nameCN":"Shire PLC","latestPrice":179.2,"timestamp":1557432000000,"preClose":179.2,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":196920000,"shares":303661068,"eps":15.745437,"marketStatus":"Delisted","change":0,"latestTime":"05-09 16:00:00 EDT","open":179.2,"high":179.2,"low":179.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":15.745437,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":179.2,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPG\",,,,,undefined,":{"symbol":"SHPG","floatShares":196920000,"roa":"--","roe":"--","lyrEps":14.136237,"shares":303661068,"dividePrice":0,"high":179.2,"amplitude":0,"preClose":179.2,"low":179.2,"week52Low":123.73,"pbRate":"1.46","week52High":182.47,"institutionHeld":0.1526,"latestPrice":179.2,"eps":15.745437,"divideRate":0,"volume":0,"delay":0,"ttmEps":15.745437,"open":179.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-01","symbol":"SHPG","fiscalQuarterEnding":"2018/09","expectedEps":3.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1541044800000,"reportTimeType":"pre","actualEps":3.64},{"market":"US","date":"2018-10-25","symbol":"SHPG","expectedEps":3.67,"name":"Shire plc","time":"Pre-Market","type":"earning","dateTimestamp":1540440000000,"reportTimeType":"pre"},{"market":"US","date":"2018-09-06","symbol":"SHPG","amount":0.168,"name":"Shire plc","currency":"USD","type":"dividend","dateTimestamp":1536206400000},{"market":"US","date":"2018-07-31","symbol":"SHPG","fiscalQuarterEnding":"2018/06","expectedEps":3.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1533009600000,"reportTimeType":"pre","actualEps":3.88},{"market":"US","date":"2018-04-26","symbol":"SHPG","fiscalQuarterEnding":"2018/03","expectedEps":3.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1524715200000,"reportTimeType":"pre","actualEps":3.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHPG\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-08","recordDate":null,"paymentDate":null,"value":0.771,"currency":"USD"},{"executeDate":"2017-09-07","recordDate":null,"paymentDate":null,"value":0.1527,"currency":"USD"},{"executeDate":"2018-03-08","recordDate":null,"paymentDate":null,"value":0.8937,"currency":"USD"},{"executeDate":"2018-09-06","recordDate":null,"paymentDate":null,"value":0.168,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHPG\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.shire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Shire plc, a biotechnology company, focuses on serving people with rare diseases and other specialized conditions. The company develops products across core therapeutic areas, including hematology, immunology, neuroscience, ophthalmics, lysosomal storage disorders, gastrointestinal/internal medicine/endocrine, and hereditary angioedema. It also focuses on developing a franchise in oncology and a pipeline in ophthalmics. Shire plc was founded in 1986 and is based in Dublin, Ireland.","exchange":"NASDAQ","name":"Shire PLC","nameEN":"Shire PLC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SHPG\",market:\"US\",,,undefined,":null}}